pharmanewsdaily
Know about fruits that help in reducing under eye circles
US pharma manufacturer Conagen acquires glycoproteins production platform
US pharma manufacturer Conagen has purchased a glycoproteins production platform – a fermentation-based technology for the production of glycoproteins used for making therapeutics, for an undisclosed price. The acquisition made from an undisclosed seller includes various patents covering the glycoproteins production platform and all related tangible assets, which are expected to place Conagen among the […]
The post US pharma manufacturer Conagen acquires glycoproteins production platform appeared first on PharmaNewsDaily.com.
Basics of Human Body & different Organ Systems
Corn Oil Cultivation, Preparation and Properties
Cinnamon Production, Medicinal Uses, Properties and Chemical Constituents
Health benefits of orange peel | Orange peel benefits for health
Eiger bags FDA breakthrough therapy status for HDV drug candidate Lambda
US biopharma company Eiger BioPharmaceuticals said that peginterferon lambda (Lambda) has been granted breakthrough therapy designation from the US Food and Drug Administration (FDA) for the treatment of hepatitis delta virus (HDV) infection. Breakthrough therapy designation enables expedition of the development and review of drugs intended for the treatment of a serious condition and where […]
The post Eiger bags FDA breakthrough therapy status for HDV drug candidate Lambda appeared first on PharmaNewsDaily.com.
Must follow daily habits to prevent acne | Acne cure home remedies
NKMax America launches SNK01-MX03 clinical trial in plaque psoriasis
SNK01-MX03 clinical trial : NKMax America, a US biotech company, has initiated a phase 1 trial called SNK01-MX03 to investigate its ex vivo expanded autologous natural killer cell therapeutic SNK in plaque psoriasis. In this connection, NKMax America treated the first patient in the SNK01-MX03 clinical trial, which is a single center, dose-escalation study for […]
The post NKMax America launches SNK01-MX03 clinical trial in plaque psoriasis appeared first on PharmaNewsDaily.com.